These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 25058347)
1. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing. Kalirai H; Dodson A; Faqir S; Damato BE; Coupland SE Br J Cancer; 2014 Sep; 111(7):1373-80. PubMed ID: 25058347 [TBL] [Abstract][Full Text] [Related]
2. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Shah AA; Bourne TD; Murali R Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622 [TBL] [Abstract][Full Text] [Related]
3. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma. Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117 [TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874 [TBL] [Abstract][Full Text] [Related]
5. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma. van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033 [TBL] [Abstract][Full Text] [Related]
6. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Koopmans AE; Verdijk RM; Brouwer RW; van den Bosch TP; van den Berg MM; Vaarwater J; Kockx CE; Paridaens D; Naus NC; Nellist M; van IJcken WF; Kiliç E; de Klein A Mod Pathol; 2014 Oct; 27(10):1321-30. PubMed ID: 24633195 [TBL] [Abstract][Full Text] [Related]
8. Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma. Farquhar N; Thornton S; Coupland SE; Coulson JM; Sacco JJ; Krishna Y; Heimann H; Taktak A; Cebulla CM; Abdel-Rahman MH; Kalirai H J Pathol Clin Res; 2018 Jan; 4(1):26-38. PubMed ID: 29416875 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up. Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584 [TBL] [Abstract][Full Text] [Related]
10. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma. Glasgow BJ; McCannel TA Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782 [TBL] [Abstract][Full Text] [Related]
11. ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures. Li J; Cao D; Jiang L; Zheng Y; Shao S; Zhuang A; Xiang D Cell Oncol (Dordr); 2024 Jun; 47(3):951-965. PubMed ID: 38150154 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma. Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622 [TBL] [Abstract][Full Text] [Related]
13. Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections. Zhang H; Kalirai H; Acha-Sagredo A; Yang X; Zheng Y; Coupland SE Transl Vis Sci Technol; 2020 Sep; 9(2):50. PubMed ID: 32953248 [TBL] [Abstract][Full Text] [Related]
14. Ki67 is a better marker than PRAME in risk stratification of BAP1-positive and BAP1-loss uveal melanomas. Donizy P; Spytek M; Krzyziński M; Kotowski K; Markiewicz A; Romanowska-Dixon B; Biecek P; Hoang MP Br J Ophthalmol; 2024 Jun; 108(7):1005-1010. PubMed ID: 37734766 [TBL] [Abstract][Full Text] [Related]
15. Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma. Kim JH; Shin SJ; Heo SJ; Choe EA; Kim CG; Jung M; Keum KC; Yoon JS; Lee SC; Shin SJ Cancer Res Treat; 2018 Oct; 50(4):1238-1251. PubMed ID: 29281872 [TBL] [Abstract][Full Text] [Related]
16. BAP1 germline mutation in two first grade family members with uveal melanoma. Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of BAP1 Protein Expression in Uveal Melanoma. Kennedy S; Owens S; Ivers L; Hegarty C; O'Neill V; Berenguer-Pina JJ; Horgan N; Crown J; Walsh N Am J Surg Pathol; 2024 Mar; 48(3):329-336. PubMed ID: 38238977 [TBL] [Abstract][Full Text] [Related]
18. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma. Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262 [TBL] [Abstract][Full Text] [Related]
19. Prognostic parameters in uveal melanoma and their association with BAP1 expression. van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369 [TBL] [Abstract][Full Text] [Related]